REAC Technology

REAC® (Radio Electric Asymmetric Conveyer) Technology, developed and patented by an Italian Research Institute, represents a revolutionary innovation in the international medical landscape. By employing specific therapeutic protocols, REAC® can precisely target the underlying mechanisms of numerous functional and organic disorders, offering a personalized, safe, and non-invasive treatment approach. REAC® Technology operates across three main therapeutic domains • Neuromodulation, aimed at optimizing the function of the central and peripheral nervous systems, with proven benefits in the treatment of mood, attention, behavioral, postural, and motor control disorders. It has also shown particular effectiveness in supporting individuals with neurodevelopmental disorders, whose prevalence is increasingly. • Biomodulation, designed to restore altered cellular and metabolic processes, reduce chronic silent inflammation, improve circulation, and support the body’s reparative functions. • Reparative and regenerative medicine, which promotes functional recovery in cases of neurological degeneration, chronic dysfunction, and tissue damage by stimulating the body's natural endogenous repair mechanisms. One of the most appreciated benefits of REAC® Technology is its ability to effectively counteract physical and cognitive aging processes, promoting health, performance, and active longevity. All REAC® treatments are administered using BENE devices, which are designed for simple, fast, and standardized use. The protocols are preset and cannot be modified by the operator, ensuring high standards of safety, reliability, and clinical reproducibility. With over thirty years of research, development, and clinical application, supported by numerous publications in international peer-reviewed scientific journals and a well-established presence in Europe, Latin America, and Asia, REAC® Technology is expanding into the Chinese and American market.